ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,520Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 1269

$1.29M Total Retail Price of All Prescriptions

Rank: 7 out of 1269

424 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

19% of this provider’s 424 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 424 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 17,411 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
METOPROLOL TARTRATE 687 563 1 6
LEVOTHYROXINE SODIUM 672 571 2 4
LISINOPRIL 624 533 3 1
AMLODIPINE BESYLATE 605 525 4 2
CITALOPRAM HBR 566 395 5 21
SIMVASTATIN 519 427 6 3
TRAMADOL HCL 495 473 7 16
FUROSEMIDE 488 447 8 5
DONEPEZIL HCL 435 415 9 22
MIRTAZAPINE 434 401 10 24
DIVALPROEX SODIUM 408 263 11 54
OLANZAPINE 402 230 12 89
QUETIAPINE FUMARATE 385 274 13 53
TRAZODONE HCL 382 310 14 36
OMEPRAZOLE 361 314 15 8
RISPERIDONE 322 230 16 43
LOVASTATIN 319 263 17 30
GLIPIZIDE 279 237 18 37
METOPROLOL SUCCINATE 274 274 19 13
PRAVASTATIN SODIUM 264 228 20 11
NAMENDA 264 250 20 38
METFORMIN HCL 250 184 22 9
BENZTROPINE MESYLATE 242 160 R 23 108
WARFARIN SODIUM 223 149 24 12
HALOPERIDOL 219 135 25 133
JANTOVEN 215 214 26 52
LEVETIRACETAM 215 150 26 55
POTASSIUM CHLORIDE 214 186 28 26
ABILIFY 208 134 29 169
SERTRALINE HCL 207 168 30 23
LACTULOSE 197 159 31 67
POLYETHYLENE GLYCOL 3350 194 185 32 50
LIDODERM 190 161 33 56
RANITIDINE HCL 189 157 34 27
SEROQUEL 188 152 35 104
PANTOPRAZOLE SODIUM 182 163 36 18
HYDROCODONE-ACETAMINOPHEN 173 155 S3 37 20
GABAPENTIN 173 146 37 17
LANTUS 151 102 39 39
TAMSULOSIN HCL 139 136 40 31
CIPROFLOXACIN HCL 138 113 41 66
HYDRALAZINE HCL 126 109 42 48
ATENOLOL 124 106 43 14
CYMBALTA 123 122 44 70
HYDROCHLOROTHIAZIDE 123 102 44 10
DIGOXIN 122 117 46 62
NYSTATIN 120 105 47 119
CARBIDOPA-LEVODOPA 120 108 47 78
LYRICA 119 71 49 92
ISOSORBIDE MONONITRATE ER 115 100 50 63
SANTYL 110 89 51 101
ALLOPURINOL 106 93 52 49
PREDNISONE 102 92 53 45
HALOPERIDOL DECANOATE 102 51 53 318
CLOPIDOGREL 95 87 55 32
OXYCODONE HCL 95 63 S2 55 34
KLOR-CON M20 91 89 57 60
NOVOLOG 91 86 57 82
ALENDRONATE SODIUM 90 88 59 28
VALPROIC ACID 89 48 60 189
CARVEDILOL 88 70 61 29
RISPERDAL CONSTA 85 57 62 329
DIOVAN 85 82 62 35
FLUPHENAZINE HCL 85 48 62 282
OXYCONTIN 84 63 S2 65 116
CLONIDINE HCL 84 80 65 51
ADVAIR DISKUS 81 44 67 46
CELEBREX 76 64 68 95
FLUOXETINE HCL 75 24 69 83
MORPHINE SULFATE ER 71 71 S2 70 118
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 67 71 84
CLOZAPINE 69 69 72 185
BACLOFEN 66 56 73 103
SPIRIVA 65 65 74 64
FENOFIBRATE 65 57 74 115
NOVOLIN R 65 52 74 211
LAMOTRIGINE 65 33 74 194
HUMALOG 64 26 78 109
OXYCODONE-ACETAMINOPHEN 62 61 S2 79 44
LATANOPROST 61 49 80 143
VENLAFAXINE HCL ER 61 43 80 140
KETOCONAZOLE 61 24 80 203
METHYLPHENIDATE HCL 60 56 83 304
GEMFIBROZIL 58 49 84 145
OXYBUTYNIN CHLORIDE 58 52 84 128
VERAPAMIL ER 58 47 84 134
PLAVIX 57 47 87 47
ZOLPIDEM TARTRATE 56 45 88 19
FINASTERIDE 53 53 89 112
OXCARBAZEPINE 52 41 90 213
HUMULIN R 50 50 91 312
EXELON 50 43 91 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.